Abstract
Type 2 diabetes mellitus (T2DM) affects 537 million people worldwide, with its prevalence and complications continuing to rise despite advancements in treatment. Identifying novel biomarkers associated with glycemic control and diabetic complications remains crucial for improving disease management. We aimed to assess and quantify the association between serum levels of CA19-9 and CEA with T2DM and glycated hemoglobin (HbA1c) levels. A literature search was conducted using various databases and twelve eligible studies that reported serum levels of CA19-9 or/and CEA in T2DM patients and non-diabetic adult group were included. The pooled analysis was conducted using the random-effects model in Review Manager 5.4.1. To explore the cause of heterogeneity, sub-group analysis and meta-regression was performed. This study highlights significant association between diabetes and elevated tumor markers. The association of CA 19-9 with BMI underscores the potential role of metabolic dysregulation. The online version contains supplementary material available at 10.1007/s13340-025-00863-5.
Keywords
Affiliated Institutions
Related Publications
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Key Words: blood glucose ◼ sodiumglucose transporter 2 ◼ treatment outcome ◼ type 2 diabetes mellitus C ardiovascular disease (CVD) is the leading cause of death in type 2 diabe...
HbA1c and all-cause mortality risk among patients with type 2 diabetes
Several prospective studies have evaluated the association between glycosylated hemoglobin (HbA1c) and death risk among diabetic patients. However, the results have been inconsi...
U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease
The objective of the U.K. Prospective Diabetes Study is to determine whether improved blood glucose control in type II diabetes will prevent the complications of diabetes and wh...
Genetics of diabetes mellitus and diabetes complications
Diabetes is one of the fastest growing diseases worldwide, projected to affect 693 million adults by 2045. Devastating macrovascular complications (cardiovascular disease) and m...
Progression of Nephropathy in Spontaneous Diabetic Rats Is Prevented by OPB-9195, a Novel Inhibitor of Advanced Glycation
Levels of tissue advanced glycation end products (AGEs) that result from nonenzymatic reactions of glucose and proteins are high in both diabetic and aging people. Irreversible ...
Publication Info
- Year
- 1977
- Type
- book-chapter
- Pages
- 433-529
- Citations
- 374
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1007/978-1-4684-3180-3_10
- PMID
- 41356117
- PMCID
- PMC12675849